登录

Anaut宣布日本监管部门批准人工智能手术可视化工具Eurekaα

Anaut Announces Japanese Regulatory Approval of AI-Powered Surgical Visualization Tool, Eureka α

BioSpace | 2024-05-02 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


Eureka α is Japan's first software as a medical device to support surgeons' visual recognition in real time

Eurekaα是日本第一款支持外科医生实时视觉识别的医疗设备软件

TOKYO, May 2, 2024 /PRNewswire/ -- Anaut Inc., a pioneering developer in surgical support software led by CEO Dr. Nao Kobayashi, announced regulatory approval of its groundbreaking medical device, 'Eureka α'. This first-of-its-kind software device in Japan received approval from the Ministry of Health, Labour and Welfare on April 12, 2024 (approval number: 30600BZX00061000) and is set to transform surgical practices with its advanced artificial intelligence capabilities..

东京,2024年5月2日/PRNewswire/--由首席执行官小林博士领导的外科支持软件先驱Anaut Inc.宣布其开创性医疗设备“Eurekaα”获得监管部门批准。2024年4月12日,日本第一款同类软件设备获得了厚生劳动省的批准(批准号:30600BZX00061000),并将以其先进的人工智能功能改变手术实践。。

Innovative Surgical Assistance

创新的手术辅助

Eureka α utilizes state-of-the-art AI to analyze real-time video from laparoscopic and robotic surgery, enhancing surgeons' accuracy by highlighting the dissection planes characterized by connective tissue. Connective tissue, critical in surgical navigation, acts as a key landmark during surgeries. Known variably as the 'dissection plane' or 'holy plane', its proper identification is crucial for safe and effective surgical outcomes.

Eurekaα利用最先进的AI分析腹腔镜和机器人手术的实时视频,通过突出以结缔组织为特征的解剖平面来提高外科医生的准确性。结缔组织在手术导航中至关重要,是手术过程中的关键标志。它被称为“解剖平面”或“神圣平面”,正确的识别对于安全有效的手术结果至关重要。

Visualization of connective tissue is critical in almost any surgical procedure in the abdomen, including those that involve the stomach, large intestine, and abdominal hernias..

结缔组织的可视化在几乎所有腹部外科手术中都是至关重要的,包括涉及胃,大肠和腹股沟疝的手术。。

Eureka α offers a secondary monitor view that differs from the primary surgical display to optimize the surgeon's visual field. Supported by expert-guided training data, the technology harnesses deep learning and computer vision technologies to improve surgical precision and safety.

Eurekaα提供了与主要手术显示不同的二次监视器视图,以优化外科医生的视野。在专家指导的培训数据的支持下,该技术利用深度学习和计算机视觉技术来提高手术精度和安全性。

Development and Collaborative Efforts

发展和合作努力

The development of Eureka α was made possible by a robust partnership with over 20 of Japan's largest and most prominent academic research institutions and medical university hospitals. This initiative has also received backing from significant public organizations such as the Tokyo Metropolitan Government, the New Energy and Industrial Technology Development Organization (NEDO), the Japan External Trade Organization (JETRO), Kawasaki City, and others..

与20多家日本最大和最著名的学术研究机构和医科大学医院建立了强大的合作伙伴关系,使Eurekaα的发展成为可能。这一举措也得到了东京都政府、新能源和工业技术发展组织(NEDO)、日本对外贸易组织(JETRO)、川崎市等重要公共组织的支持。。

A Leap Forward in Surgical Standards

外科标准的飞跃

Japan has long been recognized for its high safety standards in surgery, aided by technical accreditation systems and a focus on laparoscopic and robot-assisted techniques. Eureka α represents a pivotal advancement in supporting surgical operations, particularly benefiting young surgeons in mastering complex procedures through enhanced visual guidance and increased confidence in surgical performance..

长期以来,日本因其在外科手术中的高安全标准而得到认可,这得益于技术认证系统以及对腹腔镜和机器人辅助技术的关注。Eurekaα代表了支持外科手术的关键进步,特别是通过增强视觉指导和增强对手术表现的信心,使年轻外科医生掌握复杂的手术。。

Future Prospects and Global Aspirations

未来前景和全球愿望

Following the success in Japan of its flagship product, Surgical Vision Eureka, which is employed in educational and research settings as a non-medical device, Anaut Inc. plans to expand the applications of its technology to include gynecological and urological surgeries. With no equivalent devices currently approved for clinical use outside of Japan, Eureka α has garnered international attention, paving the way for expansion into the US and global markets..

继其旗舰产品Surgical Vision Eureka在日本取得成功后,Anaut Inc.计划将其技术的应用扩展到妇科和泌尿外科手术,该产品作为非医疗设备用于教育和研究环境。由于目前在日本以外没有批准用于临床的等效设备,Eurekaα已经引起了国际关注,为扩展到美国和全球市场铺平了道路。。

About Anaut Inc.

关于Anaut Inc。

Founded in July 2020 in Tokyo, Japan by a team of surgeons, engineers, and business professionals, Anaut Inc. aims to merge cutting-edge engineering with surgical expertise to develop technologies that enhance patient care worldwide, including decreased complications and higher efficiency. 'A nautical mission in the ocean of anatomy,' the company continues to innovate at the intersection of technology and human health..

Anaut Inc.于2020年7月在日本东京成立,由外科医生、工程师和商业专业人员组成,旨在将尖端工程与外科专业知识相结合,开发出可增强全球患者护理的技术,包括减少并发症和提高效率。”“解剖学海洋中的航海使命”,该公司在技术和人类健康的交叉点上不断创新。。

Contact

联系人

James Y. Grosvenor

詹姆斯·格罗夫纳

Global Business Development

全球业务发展

Anaut Inc.

Anaut股份有限公司。

eureka@anaut-surg.com

eureka@anaut-surg.com

Visit our website at https://anaut-surg.com/en/ for further details.

访问我们的网站https://anaut-surg.com/en/有关更多详细信息。

View original content to download multimedia:https://www.prnewswire.com/news-releases/anaut-announces-japanese-regulatory-approval-of-ai-powered-surgical-visualization-tool-eureka--302134627.html

查看原始内容以下载多媒体:https://www.prnewswire.com/news-releases/anaut-announces-japanese-regulatory-approval-of-ai-powered-surgical-visualization-tool-eureka--302134627.html

SOURCE Anaut Inc.

资料来源:Anaut公司。

推荐阅读

Signal Transduct Target Ther:在胆汁和血清样本中发现的外泌体环状RNA可作为胆管癌临床管理的一种新的诊断和预后工具

生物谷 2024-05-18 11:52

柳叶刀分析10万中国人,文化程度较低,死亡风险或增加93%,呼吸系统疾病死亡高3倍

生物谷 2024-05-18 11:52

PNAS:抑制SIRT2改善肠道上皮屏障完整性并抑制小鼠小结肠炎

生物谷 2024-05-18 11:52

BioSpace

2640篇

最近内容 查看更多

Marvel Biosciences宣布私募

5 小时前

NervGen制药公司将在美国脊髓损伤协会第51届年度科学会议上展示两张海报

5 小时前

Biogen在早期读数后放弃Ionis在ALS、Angelman综合征中的合作资产

6 小时前

产业链接查看更多

所属赛道

医疗机器人
近30天,融资3起